carvedilol has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dun, Y; Sun, HY; Zhao, RR; Zhao, ZQ; Zhi, JM | 1 |
1 other study(ies) available for carvedilol and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Article | Year |
---|---|
Activated polymorphonuclear leukocytes induce cardiomyocyte apoptosis and the protective effects of carvedilol.
Topics: Animals; Animals, Newborn; Antioxidants; Apoptosis; Carbazoles; Carvedilol; Cells, Cultured; DNA Fragmentation; Enzyme Inhibitors; Flow Cytometry; Imidazoles; In Situ Nick-End Labeling; Microscopy, Electron; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Neutrophils; p38 Mitogen-Activated Protein Kinases; Platelet Activating Factor; Propanolamines; Pyridines; Rats; Signal Transduction | 2002 |